Brazil Biomaterials Market

Brazil Biomaterials Market (2010-2015)

Report Code: BT 1607 May, 2011, by marketsandmarkets.com

The Brazil market for biomaterials is expected to reach $1.7 billion in 2015 from $550.2 million in 2008 with a CAGR of 19.5% from 2010 to 2015. In 2009, the orthopedic biomaterial market recorded revenues of $236.5 million or 37.5% of the total biomaterial products market. This is mainly because of increasing application areas and introduction of sophisticated technologies in the biomaterials market. However, the orthopedic biomaterial market is estimated to grow at a CAGR of 17.2% from 2010 to 2015. Cardiovascular biomaterial products market is the second-highest market, contributing 36% of the total biomaterial products market.

Aging population (population above 60 years is expected to reach 24 million by 2012), higher life expectancy, and increase in the incidences of ‘lifestyle and chronic diseases’ such as cardiovascular diseases has influenced the growth of biomaterial products. According to the World Health Organization, 32% of the total mortality in Brazil is due to cardiovascular diseases. Such a high incidence of diseases will increase the demand for cardiovascular biomaterial products such as cardiac stents.

The biomaterial products market in Brazil is expected to grow from $690 million in 2010 to $1.7 billion in 2015 at an estimated CAGR of 19.5%. The wound care biomaterial segment is expected to grow at a CAGR of 24.3% from 2010 to 2015. Of all the application areas of biomaterial in Brazil, surgical appliances and supplies account for the largest share; i.e. 39% of the total applications of biomaterial. With the technological advancements in orthopedic and prosthetic applications, there is an increase in demand for biomaterials in surgical appliances and supplies.

Markets covered

This research report categorizes the biomaterials market into the following:

  • Biomaterial market, by products: Orthopedic, cardiovascular, wound care, gastrointestinal, urological, plastic surgery and others.
  • Biomaterial market, by materials: Metals, polymers, ceramics, and composites.
  • Biomaterial market, by application: General surgery, surgical appliances and supplies, surgical and medical instruments, dental products, electro medical equipment, and other applications.

The report provides market estimates and forecasts for the Brazil biomaterial market. Plus, the report offers a detailed analysis of the market trends, opportunities, and the factors influencing the growth of each segment of the biomaterials market. The report also draws a competitive landscape, analyzing core competencies of major players and strategies adopted to expand their market presence.

Stakeholders

The targeted audience for this report includes:

  • Pharmaceutical and biotech companies
  • Medical devices manufacturers
  • Pharma-research labs
  • Doctors, physicians, and hospitals
  • Medical/pharma associations
  • Retailers and super-retailers
  • Technology providers
  • Research and development (R&D) companies

Research methodology

Secondary research is carried out using proprietary databases (both paid and public), company websites, and news articles etc. The primary research involves interviews with specialists, CEO’s, managers, and directors working with major market players (key industry participants) and subject matter experts from research institutes. Data and analytic output from secondary research such as markets drivers, restraints, growth opportunities, market forecasts, and others have been validated with primary research. Market size of the segments was calculated using the bottom-up approach and figures thus derived were added to yield the biomaterial market revenues.

Customer Interested in this report also can view

  • Biomaterials Market [By Products (Polymers, Metals, Ceramics, Natural Biomaterials) & Applications (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Ophthalmology, Neurology Disorders)] – Global Forecasts to 2017

Biomaterials are widely used in medical devices, tissue replacements, and surface coating applications. These materials are used in the human body to improve body functions and/or to replace damaged tissues. However, earlier there was no study done on biocompatibility and consequently there was no formalized approval process. Therefore, biomaterials were used only in external prosthetics and dental devices. With the emergence of biotechnology, the biomaterial market has expanded and is now playing a more significant important role in the medical sector. They have emerged from bio-inert materials (materials that do not react with the biological environment) to biodegradable materials. In 2008, the biomaterial market was worth $623.1 million; the market is expected to grow at a CAGR of 19.5% from 2010 to 2015. This indicates a great opportunity in the market in terms of revenues and market growth.

The biomaterial products market in Brazil is expected to grow from $690 million in 2010 to $1.7 billion in 2015 at an estimated CAGR of 19.5%. The wound care biomaterial segment is expected to grow at a CAGR of 24.3% from 2010 to 2015. Of all the application areas of biomaterial in Brazil, surgical appliances and supplies account for the largest share; i.e. 39% of the total applications of biomaterial. With the technological advancements in orthopedic and prosthetic applications there is an increase in demand for biomaterials in surgical appliances and supplies.

The biomaterials market includes number of materials with synthetic polymers and alloys. The improvement in natural polymers and metals has helped the growth of biomaterials. The biomaterial market is further segmented as ceramics, metals, polymers, bone, and others. Others include composites and hybrid biomaterials. These biomaterials are manufactured by combining two different biomaterials such as metal and polymers or metal and metal. Composites are mainly prepared to incorporate the properties of two different ingredients/biomaterials in one product.

Brazil has, off late, emerged as an attractive destination for medical tourism because of its quality services, excellent medical facilities, and treatment at affordable prices (about 50% less than that of U.S.).

The private healthcare delivery market in Brazil will see new entrants and some consolidation. This is likely to increase the number of hospitals and the care units. For example, the International Financial Corporation (IFC) has partially financed the private hospital chain 'Hospital e Maternidade Anαlia Franco’ of the Sao Luiz Group. The IFC extended a loan of $17 million with a 13-year final maturity and additional long-term fund of the same amount to furnish and equip the hospital. Such developments are likely to increase the number of hospitals or care units in the country.

TABLE OF CONTENTS
 
EXECUTIVE SUMMARY 
  MARKET OVERVIEW
 
1 INTRODUCTION
  1.1 KEY TAKE-AWAYS
  1.2 REPORT DESCRIPTION
  1.3 MARKETS COVERED
  1.4 STAKEHOLDERS
  1.5 RESEARCH METHODOLOGY
 
2 SUMMARY

3 MARKET OVERVIEW
  3.1 INTRODUCTION
  3.2 DEFINING THE BRAZIL BIOMATERIALS MARKET
  3.3 MARKET SIZE
  3.4 BRAZIL REGULATORY PROCESS
  3.5 DRIVING FACTOR ANALYSIS OF BRAZIL BIOMATERIALS MARKET
      3.5.1 DEMAND SIDE DRIVERS
      3.5.2 SUPPLY SIDE DRIVERS
      3.5.3 THREATS
      3.5.4 OPPORTUNITIES
      3.5.5 KEY COMPETITIVE POINTS
 
4 BIOMATERIALS MARKET – BY PRODUCTS
  4.1 INTRODUCTION
  4.2 ORTHOPEDIC BIOMATERIALS
      4.2.1 DRIVERS
            4.2.1.1 Product penetration
            4.2.1.2 Easy surgical procedures
      4.2.2 RECONSTRUCTIVE BIOMATERIALS
            4.2.2.1 Artificial knee biomaterials
                    4.2.2.1.1 Constraint implants
                    4.2.2.1.2 Non-constraint implants
                    4.2.2.1.3 Semi-constraint implants
            4.2.2.2 Artificial hip biomaterials
                    4.2.2.2.1 Cemented prostheses biomaterials
                    4.2.2.2.2 Uncemented prostheses biomaterials
      4.2.3 ORTHOBIOLOGICS BIOMATERIALS
            4.2.3.1 Machined bone allografts
            4.2.3.2 DBM
            4.2.3.3 BMP
            4.2.3.4 Synthetic bone substitutes
            4.2.3.5 Non-proprietary allografts
            4.2.3.6 Platelet concentrates
      4.2.4 BONE CEMENT
      4.2.5 TRAUMA ORTHOPEDIC BIOMATERIALS
      4.2.6 SPINAL ORTHOPEDIC BIOMATERIALS
            4.2.6.1 Cervical
            4.2.6.2 Lumbar
      4.2.7 SPORTS MEDICINE
      4.2.8 DENTAL ORTHOPEDIC BIOMATERIALS
            4.2.8.1 Dental bone graft
                    4.2.8.1.1 Dental allograft
                    4.2.8.1.2 Dental synthetic
                    4.2.8.1.3 Dental xenograft
            4.2.8.2 Dental membranes
            4.2.8.3 Tissue regeneration
  4.3 CARDIOVASCULAR BIOMATERIALS
      4.3.1 CARDIAC STENTS
      4.3.2 PERIPHERAL VASCULAR GRAFTS
      4.3.3 VASCULAR ACCESS DEVICES
      4.3.4 CARDIAC PACEMAKERS
      4.3.5 ARTIFICIAL HEART VALVES
      4.3.6 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
  4.4 WOUND CARE BIOMATERIALS
      4.4.1 SURGICAL HEMOSTATS
            4.4.1.1 Thrombin-based hemostats
            4.4.1.2 Oxidized regenerated cellulose-based hemostats
            4.4.1.3 Collagen-based hemostats
            4.4.1.4 Autologous-based biomaterials
            4.4.1.5 Polysaccharide-based biomaterials
            4.4.1.6 Gelatin-based hemostats
            4.4.1.7 Combination hemostats
      4.4.2 SKIN SUBSTITUTES
      4.4.3 INTERNAL TISSUE SEALANT
            4.4.3.1 Fibrin-based sealants
            4.4.3.2 Synthetic based sealants
      4.4.4 ADHESION BARRIERS
            4.4.4.1 Gels
            4.4.4.2 Films
  4.5 PLASTIC SURGERY BIOMATERIALS
      4.5.1 FACIAL IMPLANTS
      4.5.2 INJECTABLE FILLERS
      4.5.3 BREAST IMPLANTS
            4.5.3.1 Silicone gel implants
            4.5.3.2 Saline-filled implants
  4.6 UROLOGICAL BIOMATERIALS
      4.6.1 STENTS
      4.6.2 CATHETERS
            4.6.2.1 Dialysis catheters
            4.6.2.2 Urinary catheters
  4.7 GASTROINTESTINAL BIOMATERIALS
 
5 BIOMATERIALS MARKET – BY MATERIALS
  5.1 INTRODUCTION
  5.2 METALS
      5.2.1 PURE FORM METALS
            5.2.1.1 Titanium
            5.2.1.2 Platinum
            5.2.1.3 Silver
            5.2.1.4 Gold
      5.2.2 ALLOYS
            5.2.2.1 High carbon cobalt-chromium alloys
  5.3 CERAMICS
      5.3.1 BIOINERT
            5.3.1.1 Alumina
            5.3.1.2 Zirconia
            5.3.1.3 Others
      5.3.2 BIOACTIVE
            5.3.2.1 Bioglass
            5.3.2.2 Other bioactive ceramics market
      5.3.3 BIODEGRADABLE
            5.3.3.1 Hydroxyapetite
            5.3.3.2 Other biodegradable biomaterial market
  5.4 POLYMERS
      5.4.1 NATURAL POLYMERS
            5.4.1.1 Collagen based
            5.4.1.2 Other protein based
            5.4.1.3 Chitosan
            5.4.1.4 Alginate
      5.4.2 SYNTHETIC POLYMERS
            5.4.2.1 Hyaluronic acid
            5.4.2.2 PLA/PGA (poly lactic acid/Poly lactic-co glycolic acid)
            5.4.2.3 PTFE (polytetrafluoroethylene)
            5.4.2.4 Other synthetic polymers
 
6 BIOMATERIALS MARKET – BY APPLICATIONS
  6.1 INTRODUCTION
  6.2 SURGICAL APPLIANCES & SUPPLIES
  6.3 SURGICAL & MEDICAL INSTRUMENTS
  6.4 DRUG DELIVERY
  6.5 GENERAL SURGERY
  6.6 ELECTROMEDICAL EQUIPMENT
  6.7 DENTAL PRODUCTS
  6.8 OTHERS
 
7 COMPANY PROFILES
  7.1 ALLERGAN INC.
      7.1.1 OVERVIEW
      7.1.2 FINANCIALS
      7.1.3 PRODUCTS & SERVICES
      7.1.4 STRATEGY
      7.1.5 DEVELOPMENTS
  7.2 ALPHATEC SPINE INC.
      7.2.1 OVERVIEW
      7.2.2 FINANCIALS
      7.2.3 PRODUCTS & SERVICES
      7.2.4 STRATEGY
      7.2.5 DEVELOPMENTS
  7.3 ARTIMPLANT AB
      7.3.1 OVERVIEW
      7.3.2 PRODUCTS & SERVICES
      7.3.3 STRATEGY
      7.3.4 DEVELOPMENTS
  7.4 BAXTER INTERNATIONAL INC.
      7.4.1 OVERVIEW
      7.4.2 FINANCIALS
      7.4.3 PRODUCTS & SERVICES
      7.4.4 STRATEGY
      7.4.5 DEVELOPMENTS
  7.5 BIOMET INC.
      7.5.1 OVERVIEW
      7.5.2 FINANCIALS
      7.5.3 PRODUCTS & SERVICES
      7.5.4 STRATEGY
      7.5.5 DEVELOPMENTS
  7.6 BOSTON SCIENTIFIC CORPORATION
      7.6.1 OVERVIEW
      7.6.2 FINANCIALS
      7.6.3 PRODUCTS & SERVICES
      7.6.4 STRATEGY
      7.6.5 DEVELOPMENTS
  7.7 INTEGRA LIFE SCIENCES HOLDINGS CORPORATION
      7.7.1 OVERVIEW
      7.7.2 FINANCIALS
      7.7.3 PRODUCTS & SERVICES
      7.7.4 STRATEGY
      7.7.5 DEVELOPMENTS
  7.8 STRYKER CORPORATION
      7.8.1 OVERVIEW
      7.8.2 FINANCIALS
      7.8.3 PRODUCTS & SERVICES
      7.8.4 STRATEGY
      7.8.5 DEVELOPMENTS
  7.9 SYNTHES INC.
      7.9.1 OVERVIEW
      7.9.2 FINANCIALS
      7.9.3 PRODUCTS & SERVICES
      7.9.4 STRATEGY
      7.9.5 DEVELOPMENTS
  7.10 WRIGHT MEDICAL GROUP, INC.
      7.10.1 OVERVIEW
      7.10.2 FINANCIALS
      7.10.3 PRODUCTS & SERVICES
      7.10.4 STRATEGY
      7.10.5 DEVELOPMENTS
  

LIST OF TABLES 

1 BRAZIL BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND)
2 BRAZIL: ORTHOPEDIC BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND) 
3 BRAZIL: ORTHOPEDIC BIOMATERIALS MARKET REVENUE, BY DEVICES 2008 – 2015 ($THOUSAND)
4 MAJOR PLAYERS & PRODUCT DEVELOPMENT
5 BRAZIL: ORTHOPEDIC RECONSTRUCTIVE BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND)
6 BRAZIL: ORTHOPEDIC RECONSTRUCTIVE MARKET REVENUE, BY DEVICES 2008 – 2015 ($THOUSAND) 
7 MAJOR PLAYERS & PRODUCT DEVELOPMENT
8 BRAZIL: ARTIFICIAL KNEE BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND) 
9 BRAZIL: ARTIFICIAL HIP BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND) 
10 BRAZIL: ORTHOBIOLOGICS BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND) 
11 BRAZIL: ORTHOBIOLOGICS BIOMATERIALS MARKET REVENUE, BY DEVICES 2008 – 2015 ($THOUSAND) 
12 MAJOR PLAYERS & PRODUCT DEVELOPMENT
13 MAJOR PLAYERS & PRODUCT DEVELOPMENT
14 BRAZIL: TRAUMA ORTHOPEDIC BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND) 
15 BRAZIL: TRAUMA ORTHOPEDIC BIOMATERIALS MARKET REVENUE, BY DEVICES 2008 – 2015 ($THOUSAND) 
16 MAJOR PLAYERS & PRODUCT DEVELOPMENT
17 BRAZIL: SPINAL ORTHOPEDIC BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND) 
18 BRAZIL: SPINAL ORTHOPEDIC BIOMATERIALS MARKET REVENUE, BY DEVICES 2008 – 2015 ($THOUSAND) 
19 MAJOR PLAYERS & PRODUCT DEVELOPMENT
20 BRAZIL: CERVICAL SPINAL ORTHOPEDIC BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND)
21 BRAZIL: LUMBAR SPINAL ORTHOPEDIC BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND)
22 MAJOR PLAYERS & PRODUCT DEVELOPMENT
23 BRAZIL: DENTAL ORTHOPEDIC BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND) 
24 BRAZIL: DENTAL ORTHOPEDIC BIOMATERIALS MARKET REVENUE, BY DEVICES 2008 – 2015 ($THOUSAND) 
25 MAJOR PLAYERS & PRODUCT DEVELOPMENT
26 BRAZIL: DENTAL BONEGRAFT ORTHOPEDIC BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND)
27 BRAZIL: CARDIOVASCULAR BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND) 
28 BRAZIL: CARDIOVASCULAR BIOMATERIALS MARKET REVENUE, BY DEVICES 2008 – 2015 ($THOUSAND) 
29 MAJOR PLAYERS & PRODUCT DEVELOPMENT
30 BRAZIL: CARDIAC STENTS CARDIOVASCULAR BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND)
31 MAJOR PLAYERS & PRODUCT DEVELOPMENT
32 BRAZIL: VASCULAR ACCESS DEVICES CARDIOVASCULAR BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND)
33 MAJOR PLAYERS & PRODUCT DEVELOPMENT
34 MAJOR PLAYERS & PRODUCT DEVELOPMENT
35 BRAZIL: ARTIFICIAL HEART VALVE CARDIOVASCULAR BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND)
36 MAJOR PLAYERS & PRODUCT DEVELOPMENT
37 MAJOR PLAYERS & PRODUCT DEVELOPMENT
38 BRAZIL: WOUND CARE BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND) 
39 BRAZIL: WOUND CARE BIOMATERIALS MARKET REVENUE, BY DEVICES 2008 – 2015 ($THOUSAND)
40 MAJOR PLAYERS & PRODUCT DEVELOPMENT
41 BRAZIL: SURGICAL HEMOSTATS WOUND CARE BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND)
42 MAJOR PLAYERS & PRODUCT DEVELOPMENT
43 BRAZIL: INTERNAL TISSUE SEALANT WOUND CARE BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND)
44 MAJOR PLAYERS & PRODUCT DEVELOPMENT
45 BRAZIL: ADHESION BARRIERS WOUND CARE BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND)
46 MAJOR PLAYERS & PRODUCT DEVELOPMENT
47 BRAZIL: PLASTIC SURGERY BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND) 
48 BRAZIL: PLASTIC SURGERY BIOMATERIALS MARKET REVENUE, BY DEVICES 2008 – 2015 ($THOUSAND) 
49 MAJOR PLAYERS & PRODUCT DEVELOPMENT
50 MAJOR PLAYERS & PRODUCT DEVELOPMENT
51 MAJOR PLAYERS & PRODUCT DEVELOPMENT
52 BRAZIL: BREAST IMPLANTS PLASTIC SURGERY BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND)
53 BRAZIL: BREAST IMPLANTS PLASTIC SURGERY BIOMATERIALS MARKET REVENUE, BY DEVICES 2008 – 2015 ($THOUSAND)
54 MAJOR PLAYERS & PRODUCT DEVELOPMENT
55 BRAZIL: UROLOGICAL BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND) 
56 BRAZIL: UROLOGICAL BIOMATERIALS MARKET REVENUE, BY DEVICES 2008 – 2015 ($THOUSAND)
57 MAJOR PLAYERS & PRODUCT DEVELOPMENT
58 BRAZIL: CATHETER UROLOGICAL BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND) 
59 BRAZIL: DIALYSIS CATHETER UROLOGICAL BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND)
60 MAJOR PLAYERS & PRODUCT DEVELOPMENT
61 BRAZIL: URINARY CATHETER UROLOGICAL BIOMATERIALS MARKET REVENUE, BY PRODUCTS 2008 – 2015 ($THOUSAND)
62 MAJOR PLAYERS & PRODUCT DEVELOPMENT
63 BRAZIL: BIOMATERIALS MARKET REVENUE, BY TYPES 2008 – 2015 ($THOUSAND)
64 BRAZIL: METALS BIOMATERIALS MARKET REVENUE, BY TYPES 2008 – 2015 ($THOUSAND) 
65 MAJOR PLAYERS & PRODUCT DEVELOPMENT
66 BRAZIL: PURE FORM METALS BIOMATERIALS MARKET REVENUE, BY TYPES 2008 – 2015 ($THOUSAND) 
67 BRAZIL: ALLOY BIOMATERIALS MARKET REVENUE, BY TYPES 2008 – 2015 ($THOUSAND) 
68 MAJOR PLAYERS & PRODUCT DEVELOPMENT
69 BRAZIL CERAMICS BIOMATERIALS MARKET, BY TYPES  2008 – 2015 ($THOUSAND)
70 MAJOR PLAYERS & PRODUCT DEVELOPMENT
71 TECHNOLOGICAL ADVANCEMENTS
72 BRAZIL: BIOINERT CERAMICS BIOMATERIALS MARKET REVENUE, BY TYPES 2008 – 2015 ($THOUSAND) 
73 BRAZIL: BIOACTIVE CERAMICS BIOMATERIALS MARKET REVENUE BY TYPES 2008 – 2015 ($THOUSAND) 
74 BRAZIL: BIODEGRADABLE CERAMICS BIOMATERIALS MARKET REVENUE, BY TYPES 2008 – 2015 ($THOUSAND)
75 BRAZIL: POLYMER BIOMATERIALS MARKET REVENUE, BY POLYMERS 2008 – 2015 ($THOUSAND)
76 MAJOR PLAYERS & PRODUCT DEVELOPMENT
77 BRAZIL: NATURAL POLYMER BIOMATERIALS MARKET REVENUE, BY TYPES 2008 – 2015 ($THOUSAND) 
78 BRAZIL: SYNTHETIC POLYMER BIOMATERIALS MARKET REVENUE, BY TYPES 2008 – 2015 ($THOUSAND) 
79 BRAZIL APPLICATIONS MARKET REVENUE, 2008 – 2015 ($THOUSAND)
80 ALLERGAN REVENUES AND R&D EXPENSES ($MILLION)
81 ALLERGAN REVENUES, BY SEGMENT ($MILLION)
82 ALLERGAN MEDIACL DEVICES REVENUES, BY SEGMENT ($MILLION)
83 ALLERGAN REVENUES, BY GEOGRAPHY ($MILLION)
84 ALPHATEC SPINE REVENUES AND R&D EXPENSES ($MILLION)
85 APLHATEC SPINE REVENUES, BY GEOGRAPHY ($MILLION)
86 BAXTER SALES, BY SEGMENT ($MILLION)
87 BAXTER SALES, BY GEOGRAPHY ($MILLION)
88 BIOMET REVENUES AND R&D EXPENSES ($MILLION)
89 BIOMET REVENUES, BY SEGMENT ($MILLION)
90 BOSTON SCIENTIFIC REVENUES AND R&D EXPENSES ($MILLION)
91 BOSTON SCIENTIFIC REVENUES, BY GEOGRAPHY ($MILLION)
92 INTEGRA REVENUES AND R&D EXPENSES ($MILLION)
93 INTEGRA REVENUES, BY GEOGRAPHY ($MILLION)
94 INTEGRA REVENUES, BY SEGMENTS ($MILLION)
95 STRYKER REVENUES AND R&D EXPENSES ($MILLION)
96 STRYKER REVENUES, BY SEGMENT ($MILLION)
97 STRYKER REVENUES, BY GEOGRAPHY ($MILLION)
98 SYNTHES REVENUES AND R&D EXPENSES ($MILLION)
99 SYNTHES REVENUES, BY GEOGRAPHY ($MILLION)
100 WRIGHT MEDICAL REVENUES AND R&D EXPENSES ($MILLION)
101 WRIGHT MEDICAL REVENUES, BY SEGMENTS ($MILLION)
102 WRIGHT MEDICAL REVENUES, BY GEOGRAPHY ($MILLION) 
    
LIST OF FIGURES 

1 BRAZIL BIOMATERIALS MARKET
2 EVOLUTION OF BIOMATERIALS
3 PARENTAL STRUCTURE OF BIOMATERIALS MARKET
4 CHARACTERISTICS OF BIOMATERIALS SCIENCE
5 BIOMATERIALS MARKET: SEGMENTATION
6 BRAZIL: MARKET SHARE OF BIOMATERIALS PRODUCTS (2010)
7 BRAZIL: TYPES OF BIOMATERIALS (2010)
8 PRODUCT CLASSIFICATION LEVELS
9 FACTORS AFFECTING THE GROWTH OF BRAZIL BIOMATERIALS MARKET


    Request for detailed methodology, assumptions & how numbers were triangulated.

    Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
    7 8 1 7 5  
    • Select all
    • News-Letters with latest Market insights
    • Information & discussion on the relevant new products and services
    • Information & discussion on Market insights and Market information
    • Information & discussion on our events and conferences
      • Select all
      • Email Phone Professional and social network (Linkedin, etc)
    Custom Market Research Services

    We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

    Request Customization

    Instant Answers with GPT - Ask Now!

    Ask real questions. Get complete answers !
    Report Code
    BT 1607
    Published ON
    May, 2011
    Choose License Type
    BUY NOW
    • SHARE
    X
    Request Customization
    Speak to Analyst
    Speak to Analyst
    OR FACE-TO-FACE MEETING
    PERSONALIZE THIS RESEARCH
    • Triangulate with your Own Data
    • Get Data as per your Format and Definition
    • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
    • Any level of Personalization
    REQUEST A FREE CUSTOMIZATION
    LET US HELP YOU!
    • What are the Known and Unknown Adjacencies Impacting the Brazil Biomaterials Market
    • What will your New Revenue Sources be?
    • Who will be your Top Customer; what will make them switch?
    • Defend your Market Share or Win Competitors
    • Get a Scorecard for Target Partners
    CUSTOMIZED WORKSHOP REQUEST
    +1-888-600-6441
    • Call Us
    • +1-888-600-6441 (Corporate office hours)
    • +1-888-600-6441 (US/Can toll free)
    • +44-800-368-9399 (UK office hours)
    CONNECT WITH US
    ABOUT TRUST ONLINE
    ©2024 MarketsandMarkets Research Private Ltd. All rights reserved
    DMCA.com Protection Status Website Feedback